ResearchCon 2024 | Opening Keynote: Where We Are: CF Drug Pipeline Developments

During the opening keynote of ResearchCon 2024, speakers Art Brace, PhD, JP Clancy, MD, and Nicole Kohr speak about the dynamic landscape of cystic fibrosis research and development. Explore the breadth of therapies currently in development for CF, including genetic therapies, anti-infectives, CFTR modulators, and beyond.  
Originally recorded April 30, 2024.
00:00 | Where We Are: drug pipeline developments  
07:23 | The complexities of new drug development  
13:00 | How does CF affect the body? 
16:00 | Why cystic fibrosis transmembrane conductance regulator (CFTR) therapies make sense 
18:00 | Learn about the new CFTR modulators  
23:10 | Genetic-based therapies for modulator-ineligible/intolerant  
29:50 | What are the genetic-based therapies currently in clinical trials? 
33:24 | Understanding genetic therapeutic development for people with CF without modulators 
38:40 | Where are we with infection research? 
42:54 | Focusing on an anti-infective portfolio  
46:02 | Where are we going in drug development for 2024? 
46:43 | How to make the best out of ResearchCon

[@joannetaylor8635]

since the cf gene has been discovered, why haven't researchers corrected it And then offered it to cf patients ?